ZJ24F0809750Determine the necessary mass, volume, or concentration for preparing a solution.
Larcaviximab (anti-EBOV) (Ab182762) - SEC
The purity of Larcaviximab (anti-EBOV) (Ab182762) is more than 95% verified by HPLC.
Larcaviximab (anti-EBOV) - Primary antibody, specific to Zaire Ebola virus, Human IgG1, INHIBITOR of Envelope glycoprotein inhibitor
Features and benefits
- Host species: Human
- Species reactivity(Reacts with): Zaire Ebola virus
- Isotype: Human IgG1
- Conjugation: Unconjugated
Item Number
Ab182762
| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| Ab182762-100μg | 100μg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $59.90 | |
| Ab182762-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $289.90 | |
| Ab182762-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $749.90 | |
| Ab182762-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,189.90 |